Diabetes & Metabolism Journal

Skip Navigation: Skip to contents

: Search

Home
Current
- Current issue
- Ahead-of print
Browse
Collections
For contributors
- For Authors
- Instructions for authors
- Article processing charge
- For Reviewers
- Instructions for reviewers
- How to become a reviewer
- Best reviewers
- For Readers
- Readership
- Subscription
- Permission guidelines
About
Editorial policy
E-Submission

OPEN ACCESS

mobile menu button

Current
- Current issue
- Ahead-of print
Browse
Collections
For contributors
- For Authors
- Instructions for authors
- Article processing charge
- For Reviewers
- Instructions for reviewers
- How to become a reviewer
- Best reviewers
- For Readers
- Readership
- Subscription
- Permission guidelines
About
Editorial policy

Search

Page Path: HOME > Search

Letter

Risk of Diabetic Retinopathy between Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists (Diabetes Metab J 2023;47:394-404): Jihee Ko, Sun Joon Moon; Diabetes Metab J. 2023;47(4):571-572. Published online July 27, 2023; DOI: https://doi.org/10.4093/dmj.2023.0164

2,245 View
95 Download
1 Crossref

PDF PubReader ePub

Citations

Citations to this article as recorded by

Multi-omics in exploring the pathophysiology of diabetic retinopathy
Xinlu Li, XiaoJing Dong, Wen Zhang, Zhizhou Shi, Zhongjian Liu, Yalian Sa, Li Li, Ninghua Ni, Yan Mei
Frontiers in Cell and Developmental Biology.2024;[Epub] CrossRef

First
Prev
Page of 1
Next
Last

ABOUT
BROWSE ARTICLES
EDITORIAL POLICY
FOR CONTRIBUTORS
- For Authors
- Instructions for authors
- Article processing charge
- For Reviewers
- Instructions for reviewers
- How to become a reviewer
- Best reviewers
- For Readers
- Readership
- Subscription
- Permission guidelines

Email address

Sign up for the DMJ newsletter—
what matters in science, free to your inbox daily.

TOP